These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 36455758)

  • 1. Macrophage xCT deficiency drives immune activation and boosts responses to immune checkpoint blockade in lung cancer.
    Tang B; Wang Y; Xu W; Zhu J; Weng Q; Chen W; Fang S; Yang Y; Qiu R; Chen M; Mao W; Xu M; Zhao Z; Cai S; Zhang H; Ji J
    Cancer Lett; 2023 Feb; 554():216021. PubMed ID: 36455758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted xCT-mediated Ferroptosis and Protumoral Polarization of Macrophages Is Effective against HCC and Enhances the Efficacy of the Anti-PD-1/L1 Response.
    Tang B; Zhu J; Wang Y; Chen W; Fang S; Mao W; Xu Z; Yang Y; Weng Q; Zhao Z; Chen M; Ji J
    Adv Sci (Weinh); 2023 Jan; 10(2):e2203973. PubMed ID: 36442849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting macrophage Syk enhances responses to immune checkpoint blockade and radiotherapy in high-risk neuroblastoma.
    Rohila D; Park IH; Pham TV; Jones R; Tapia E; Liu KX; Tamayo P; Yu A; Sharabi AB; Joshi S
    Front Immunol; 2023; 14():1148317. PubMed ID: 37350973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rational combination of an immune checkpoint inhibitor with CSF1R inhibitor-loaded nanoparticle enhances anticancer efficacy.
    Ramesh A; Malik V; Ranjani HA; Smith H; Kulkarni AA
    Drug Deliv Transl Res; 2021 Dec; 11(6):2317-2327. PubMed ID: 34365577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ILT4 inhibition prevents TAM- and dysfunctional T cell-mediated immunosuppression and enhances the efficacy of anti-PD-L1 therapy in NSCLC with EGFR activation.
    Chen X; Gao A; Zhang F; Yang Z; Wang S; Fang Y; Li J; Wang J; Shi W; Wang L; Zheng Y; Sun Y
    Theranostics; 2021; 11(7):3392-3416. PubMed ID: 33537094
    [No Abstract]   [Full Text] [Related]  

  • 6. Converged Rab37/IL-6 trafficking and STAT3/PD-1 transcription axes elicit an immunosuppressive lung tumor microenvironment.
    Kuo IY; Yang YE; Yang PS; Tsai YJ; Tzeng HT; Cheng HC; Kuo WT; Su WC; Chang CP; Wang YC
    Theranostics; 2021; 11(14):7029-7044. PubMed ID: 34093869
    [No Abstract]   [Full Text] [Related]  

  • 7. Hedgehog signaling promotes tumor-associated macrophage polarization to suppress intratumoral CD8+ T cell recruitment.
    Petty AJ; Li A; Wang X; Dai R; Heyman B; Hsu D; Huang X; Yang Y
    J Clin Invest; 2019 Dec; 129(12):5151-5162. PubMed ID: 31638600
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Delicaflavone reactivates anti-tumor immune responses by abrogating monocytic myeloid cell-mediated immunosuppression.
    Li L; You W; Wang X; Zou Y; Yao H; Lan H; Lin X; Zhang Q; Chen B
    Phytomedicine; 2023 Jan; 108():154508. PubMed ID: 36332384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TGF-β-induced IRAK-M expression in tumor-associated macrophages regulates lung tumor growth.
    Standiford TJ; Kuick R; Bhan U; Chen J; Newstead M; Keshamouni VG
    Oncogene; 2011 May; 30(21):2475-84. PubMed ID: 21278795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of macrophage polarization and lung cancer cell stemness by MUC1 and development of a related small-molecule inhibitor pterostilbene.
    Huang WC; Chan ML; Chen MJ; Tsai TH; Chen YJ
    Oncotarget; 2016 Jun; 7(26):39363-39375. PubMed ID: 27276704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor cell-released autophagosomes (TRAPs) promote immunosuppression through induction of M2-like macrophages with increased expression of PD-L1.
    Wen ZF; Liu H; Gao R; Zhou M; Ma J; Zhang Y; Zhao J; Chen Y; Zhang T; Huang F; Pan N; Zhang J; Fox BA; Hu HM; Wang LX
    J Immunother Cancer; 2018 Dec; 6(1):151. PubMed ID: 30563569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination of ultrasound-based mechanical disruption of tumor with immune checkpoint blockade modifies tumor microenvironment and augments systemic antitumor immunity.
    Abe S; Nagata H; Crosby EJ; Inoue Y; Kaneko K; Liu CX; Yang X; Wang T; Acharya CR; Agarwal P; Snyder J; Gwin W; Morse MA; Zhong P; Lyerly HK; Osada T
    J Immunother Cancer; 2022 Jan; 10(1):. PubMed ID: 35039461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comprehensive Integrative Analysis Reveals the Association of
    Arora S; Singh P; Ahmad S; Ahmad T; Dohare R; Almatroodi SA; Alrumaihi F; Rahmani AH; Syed MA
    Cells; 2021 Aug; 10(8):. PubMed ID: 34440860
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sophoridine suppresses macrophage-mediated immunosuppression through TLR4/IRF3 pathway and subsequently upregulates CD8
    Zhuang H; Dai X; Zhang X; Mao Z; Huang H
    Biomed Pharmacother; 2020 Jan; 121():109636. PubMed ID: 31733580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting the vascular endothelial growth factor receptor-1 by the monoclonal antibody D16F7 to increase the activity of immune checkpoint inhibitors against cutaneous melanoma.
    Lacal PM; Atzori MG; Ruffini F; Scimeca M; Bonanno E; Cicconi R; Mattei M; Bernardini R; D'Atri S; Tentori L; Graziani G
    Pharmacol Res; 2020 Sep; 159():104957. PubMed ID: 32485280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The HDAC2-SP1 Axis Orchestrates Protumor Macrophage Polarization.
    Zheng X; Sarode P; Weigert A; Turkowski K; Chelladurai P; Günther S; Kuenne C; Winter H; Stenzinger A; Reu S; Grimminger F; Stiewe T; Seeger W; Pullamsetti SS; Savai R
    Cancer Res; 2023 Jul; 83(14):2345-2357. PubMed ID: 37205635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blocking P2X7-Mediated Macrophage Polarization Overcomes Treatment Resistance in Lung Cancer.
    Qin J; Zhang X; Tan B; Zhang S; Yin C; Xue Q; Zhang Z; Ren H; Chen J; Liu M; Qian M; Du B
    Cancer Immunol Res; 2020 Nov; 8(11):1426-1439. PubMed ID: 32933967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of xCT suppresses the efficacy of anti-PD-1/L1 melanoma treatment through exosomal PD-L1-induced macrophage M2 polarization.
    Liu N; Zhang J; Yin M; Liu H; Zhang X; Li J; Yan B; Guo Y; Zhou J; Tao J; Hu S; Chen X; Peng C
    Mol Ther; 2021 Jul; 29(7):2321-2334. PubMed ID: 33744468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor-targeted interleukin-12 synergizes with entinostat to overcome PD-1/PD-L1 blockade-resistant tumors harboring MHC-I and APM deficiencies.
    Minnar CM; Chariou PL; Horn LA; Hicks KC; Palena C; Schlom J; Gameiro SR
    J Immunother Cancer; 2022 Jun; 10(6):. PubMed ID: 35764364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. USP7 targeting modulates anti-tumor immune response by reprogramming Tumor-associated Macrophages in Lung Cancer.
    Dai X; Lu L; Deng S; Meng J; Wan C; Huang J; Sun Y; Hu Y; Wu B; Wu G; Lovell JF; Jin H; Yang K
    Theranostics; 2020; 10(20):9332-9347. PubMed ID: 32802195
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.